Sat Kartar Shopping Limited — Important, 18-04-2026: Updates

Sat Kartar Life plans a ~₹48.59 Cr fundraise through preferential issue of equity shares and convertible warrants to boost its integrated healthcare platform. Separately, it will acquire the remaining 24% of Plantomed Neutraceuticals for ₹1.21 Cr, making it a wholly-owned subsidiary for product and brand growth.